Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$100.86
Market cap
$547.81M
P/E Ratio
N/A
Dividend/share
$0.64
EPS
-$45.61
Enterprise value
$728.46M
Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries.
Highlights
The gross profit has grown by 10% YoY and by 2.4% from the previous quarter
MLAB's revenue is up by 7% year-on-year and by 2.1% since the previous quarter
MLAB's equity has dropped by 58% year-on-year but it is up by 7% since the previous quarter
The debt has grown by 20% YoY but it has contracted by 3.4% from the previous quarter
The company's quick ratio has shrunk by 77% YoY and by 64% QoQ
Key stats
What are the main financial stats of MLAB
Market
Valuations
Earnings
Shares outstanding
5.43M
Market cap
$547.81M
Enterprise value
$728.46M
Price to book (P/B)
3.38
Price to sales (P/S)
2.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.19
Revenue
$228.38M
EBIT
-$256.07M
EBITDA
-$229.19M
Free cash flow
$35.78M
Per share
Balance sheet
Liquidity
EPS
-$45.61
Free cash flow per share
$6.61
Book value per share
$29.85
Revenue per share
$42.19
TBVPS
$29.84
Total assets
$454.1M
Total liabilities
$292.65M
Debt
$204.98M
Equity
$161.45M
Working capital
-$45.25M
Debt to equity
1.27
Current ratio
0.7
Quick ratio
0.42
Net debt/EBITDA
-0.79
Margins
Efficiency
Dividend
EBITDA margin
-100.4%
Gross margin
62.5%
Net margin
-107.6%
Operating margin
-113.5%
Return on assets
-47.2%
Return on equity
-114.2%
Return on invested capital
-93.6%
Return on capital employed
-85.1%
Return on sales
-112.1%
Dividend yield
0.63%
DPS
$0.64
Payout ratio
N/A
MLAB stock price
How has the Mesa Laboratories stock price performed over time
Intraday
2.3%
1 week
-3.58%
1 month
-24.34%
1 year
13.9%
YTD
-3.73%
QTD
-22.33%
Financial performance
How have Mesa Laboratories's revenue and profit performed over time
Revenue
$228.38M
Gross profit
$142.66M
Operating income
-$259.26M
Net income
-$245.65M
Gross margin
62.5%
Net margin
-107.6%
The gross profit has grown by 10% YoY and by 2.4% from the previous quarter
MLAB's revenue is up by 7% year-on-year and by 2.1% since the previous quarter
The operating margin has grown by 4.7% from the previous quarter
The net margin has grown by 3.8% from the previous quarter
Growth
What is Mesa Laboratories's growth rate over time
Valuation
What is Mesa Laboratories stock price valuation
P/E
N/A
P/B
3.38
P/S
2.39
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.19
MLAB's equity has dropped by 58% year-on-year but it is up by 7% since the previous quarter
MLAB's price to book (P/B) is 9% more than its 5-year quarterly average of 3.1 and 6% more than its last 4 quarters average of 3.2
The P/S is 63% below the 5-year quarterly average of 6.4 and 8% below the last 4 quarters average of 2.6
MLAB's revenue is up by 7% year-on-year and by 2.1% since the previous quarter
Efficiency
How efficient is Mesa Laboratories business performance
MLAB's return on equity is down by 24% since the previous quarter
The return on assets has declined by 7% since the previous quarter
The company's return on sales rose by 4.8% QoQ
Mesa Laboratories's return on invested capital has decreased by 2.9% QoQ
Dividends
What is MLAB's dividend history
DPS
$0.64
Dividend yield
0.63%
Payout ratio
N/A
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Mesa Laboratories financials performed over time
Mesa Laboratories's total assets is 55% more than its total liabilities
The company's quick ratio has shrunk by 77% YoY and by 64% QoQ
MLAB's current ratio has dropped by 76% year-on-year and by 64% since the previous quarter
The debt is 27% more than the equity
MLAB's debt to equity has soared by 189% YoY but it is down by 10% QoQ
MLAB's equity has dropped by 58% year-on-year but it is up by 7% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.